Regulation And Legal
Aurobindo Pharma's Eugia Unit Gets US FDA OAI Classification
Aurobindo Pharma discloses US FDA classified its Eugia Pharma subsidiary's Unit-I facility as OAI post-February 2026 inspection.
The inspection concluded with 4 observations but the company states no
